Mamas Mamas, Birgitte Krogsgaard Andersen, and Niels Ramsing Holm, discuss the merits of QFR versus FFR to guide coronary revascularization.
Britton Scheuermann, MS, shares how researchers validated the new tool’s ability to predict 10-year risk of mortality.
Robert Schwartz sits down with Shira Burg, whose company, Symbiosis, won this year's Jon DeHaan Award for their invention, the ValSync TMVR system.
Enter the email you used to register to reset your password.
Sign up to receive the most important cardiovascular news, research, and major meeting presentations.
